Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiaikang
- Development stage
- Phase 2
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Yiaikang is a patented traditional Chinese medicine formulation used primarily in the management of HIV/AIDS. It contains a combination of herbal ingredients, including ginseng (Panax ginseng), astragalus (Huangqi, Astragalus membranaceus), and Atractylodes macrocephala (Chaobaishu), among others. The formulation is designed to support immune function and improve the quality of life in patients with AIDS. Clinical studies have evaluated its effects on survival rates and symptom management in people living with HIV/AIDS[3][4]. The precise mechanism of action is not fully elucidated but is believed to involve immunomodulatory effects attributed to its herbal components.
- Brand names
- yiaikang
- Other names
- yi ai kang
02
Targets
CCR5 (C-C chemokine receptor type 5)CXCR4 (C-X-C motif chemokine receptor 4)Rev (Regulator of expression of virion proteins)Tat (HIV-1 Tat)ICAM1 (Intercellular Adhesion Molecule 1)KLRC1 (Killer cell lectin-like receptor subfamily C member 1)
Beyond the preview
Go deeper on yiaikang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiaikang.